Literature DB >> 15469910

Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion.

Christopher Cianci1, David R Langley, Douglas D Dischino, Yaxiong Sun, Kuo-Long Yu, Anne Stanley, Julia Roach, Zhufang Li, Richard Dalterio, Richard Colonno, Nicholas A Meanwell, Mark Krystal.   

Abstract

Trimeric class I virus fusion proteins undergo a series of conformational rearrangements that leads to the association of C- and N-terminal heptad repeat domains in a "trimer-of-hairpins" structure, facilitating the apposition of viral and cellular membranes during fusion. This final fusion hairpin structure is sustained by protein-protein interactions, associations thought initially to be refractory to small-molecule inhibition because of the large surface area involved. By using a photoaffinity analog of a potent respiratory syncytial virus fusion inhibitor, we directly probed the interaction of the inhibitor with its fusion protein target. Studies have shown that these inhibitors bind within a hydrophobic cavity formed on the surface of the N-terminal heptad-repeat trimer. In the fusogenic state, this pocket is occupied by key amino acid residues from the C-terminal heptad repeat that stabilize the trimer-of-hairpins structure. The results indicate that a low-molecular-weight fusion inhibitor can interfere with the formation or consolidation of key structures within the hairpin moiety that are essential for membrane fusion. Because analogous cavities are present in many class I viruses, including HIV, these results demonstrate the feasibility of this approach as a strategy for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469910      PMCID: PMC523459          DOI: 10.1073/pnas.0406696101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.

Authors:  M Ferrer; T M Kapoor; T Strassmaier; W Weissenhorn; J J Skehel; D Oprian; S L Schreiber; D C Wiley; S C Harrison
Journal:  Nat Struct Biol       Date:  1999-10

2.  A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.

Authors:  S Jiang; A K Debnath
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

3.  The trimer-of-hairpins motif in membrane fusion: Visna virus.

Authors:  V N Malashkevich; M Singh; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 4.  Virus membrane fusion proteins: biological machines that undergo a metamorphosis.

Authors:  R E Dutch; T S Jardetzky; R A Lamb
Journal:  Biosci Rep       Date:  2000-12       Impact factor: 3.840

5.  Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.

Authors:  D M Eckert; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 6.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

7.  Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution.

Authors:  W F Vranken; F Fant; M Budesinsky; F A Borremans
Journal:  Eur J Biochem       Date:  2001-05

8.  Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex.

Authors:  M K Lawless-Delmedico; P Sista; R Sen; N C Moore; J B Antczak; J M White; R J Greene; K C Leanza; T J Matthews; D M Lambert
Journal:  Biochemistry       Date:  2000-09-26       Impact factor: 3.162

9.  Structural characterization of the human respiratory syncytial virus fusion protein core.

Authors:  X Zhao; M Singh; V N Malashkevich; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

10.  Modelling the structure of the fusion protein from human respiratory syncytial virus.

Authors:  Brian J Smith; Michael C Lawrence; Peter M Colman
Journal:  Protein Eng       Date:  2002-05
View more
  45 in total

1.  Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

Authors:  Margarita Magro; David Andreu; Paulino Gómez-Puertas; José A Melero; Concepción Palomo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Site-directed antibodies against the stem region reveal low pH-induced conformational changes of the Semliki Forest virus fusion protein.

Authors:  Maofu Liao; Margaret Kielian
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.

Authors:  Gary Frey; Sophia Rits-Volloch; X-Q Zhang; Robert T Schooley; Bing Chen; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

4.  Live-cell characterization and analysis of a clinical isolate of bovine respiratory syncytial virus, using molecular beacons.

Authors:  Philip Santangelo; Nitin Nitin; Leslie LaConte; Amelia Woolums; Gang Bao
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform.

Authors:  Minyoung Park; Hisae Matsuura; Robert A Lamb; Annelise E Barron; Theodore S Jardetzky
Journal:  Anal Biochem       Date:  2010-11-05       Impact factor: 3.365

6.  The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.

Authors:  Julia Eckardt-Michel; Markus Lorek; Diane Baxmann; Thomas Grunwald; Günther M Keil; Gert Zimmer
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

7.  Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein.

Authors:  Dirk Roymans; Hendrik L De Bondt; Eric Arnoult; Peggy Geluykens; Tom Gevers; Marcia Van Ginderen; Nick Verheyen; Hidong Kim; Rudy Willebrords; Jean-François Bonfanti; Wouter Bruinzeel; Maxwell D Cummings; Herman van Vlijmen; Koen Andries
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

Review 8.  Therapeutic Potential of Spirooxindoles as Antiviral Agents.

Authors:  Na Ye; Haiying Chen; Eric A Wold; Pei-Yong Shi; Jia Zhou
Journal:  ACS Infect Dis       Date:  2016-05-05       Impact factor: 5.084

9.  Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2-Phenylacetyl Amino-Benzamide.

Authors:  Michael N Ha; Sébastien Delpeut; Ryan S Noyce; Gary Sisson; Karen M Black; Liang-Tzung Lin; Darius Bilimoria; Richard K Plemper; Gilbert G Privé; Christopher D Richardson
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

10.  Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.

Authors:  Dan Yan; Sujin Lee; Vidhi D Thakkar; Ming Luo; Martin L Moore; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.